Overview
Yuzo Ikari practices practicing medicine in Tokyo, Japan.
Their clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Systemic Sclerosis (SSc), and Scleroderma.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yuzo Ikari
Is Yuzo Ikari a top-rated expert for Rheumatoid Arthritis (RA)?
MediFind is an objective health platform that identifies experts based on real-world data. Yuzo Ikari is classified as an Experienced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yuzo Ikari participate in research or clinical trials?
Yes. Yuzo Ikari has published 12 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Yuzo Ikari's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ArthritisIkari isExperienced. Learn about Arthritis.
- Rheumatoid Arthritis (RA)Ikari isExperienced. Learn about Rheumatoid Arthritis (RA).
- SclerodermaIkari isExperienced. Learn about Scleroderma.
- Systemic Sclerosis (SSc)Ikari isExperienced. Learn about Systemic Sclerosis (SSc).